These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7259668)

  • 1. Localized cutaneous pseudolymphoma associated with phenytoin therapy: a case report.
    Adams JD
    Australas J Dermatol; 1981 Apr; 22(1):28-9. PubMed ID: 7259668
    [No Abstract]   [Full Text] [Related]  

  • 2. Phenytoin-induced pseudolymphoma with mycosis fungoides manifestations.
    Cooke LE; Hardin TC; Hendrickson DJ
    Clin Pharm; 1988 Feb; 7(2):153-7. PubMed ID: 3349752
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug-induced pseudolymphoma with predominantly cutaneous manifestation].
    Sigal M; Pulik M
    Ann Dermatol Venereol; 1993; 120(2):175-80. PubMed ID: 8363313
    [No Abstract]   [Full Text] [Related]  

  • 4. Generalized nodular cutaneous pseudolymphoma associated with phenytoin therapy. Use of T-cell receptor gene rearrangement in diagnosis and clinical review of cutaneous reactions to phenytoin.
    Braddock SW; Harrington D; Vose J
    J Am Acad Dermatol; 1992 Aug; 27(2 Pt 2):337-40. PubMed ID: 1517500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenytoin-induced pseudolymphoma. A report of a case and review of the literature.
    Harris DW; Ostlere L; Buckley C; Whittaker S; Sweny P; Rustin MH
    Br J Dermatol; 1992 Oct; 127(4):403-6. PubMed ID: 1419762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenytoin-induced pseudolymphoma syndrome: an immunologic study.
    Charlesworth EN
    Arch Dermatol; 1977 Apr; 113(4):477-80. PubMed ID: 848977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydantoin-induced cutaneous pseudolymphoma with clinical, pathologic, and immunologic aspects of Sézary syndrome.
    D'Incan M; Souteyrand P; Bignon YJ; Fonck Y; Roger H
    Arch Dermatol; 1992 Oct; 128(10):1371-4. PubMed ID: 1417026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudolymphoma induced by diphenylhydantoin.
    Choovivathanavanich P; Wallace EM; Scaglione PR
    J Pediatr; 1970 Apr; 76(4):621-3. PubMed ID: 5420803
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenytoin-induced lymphadenopathy.
    Schwinghammer TL; Howrie DL
    Drug Intell Clin Pharm; 1983 Jun; 17(6):460-2. PubMed ID: 6861635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudolymphoma with mycosis fungoides manifestations, hyperresponsiveness to diphenylhydantoin, and lymphocyte disregulation.
    Rosenthal CJ; Noguera CA; Coppola A; Kapelner SN
    Cancer; 1982 Jun; 49(11):2305-14. PubMed ID: 6978761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of diphenylhydantoin-induced pseudo-pseudolymphoma (author's transl)].
    Matsuo T; Matsumoto A; Miyasaki K
    Nihon Naika Gakkai Zasshi; 1977 Mar; 66(3):317-21. PubMed ID: 559053
    [No Abstract]   [Full Text] [Related]  

  • 12. Pseudolymphoma induced by diphenylhydantoin.
    Gams RA
    J Pediatr; 1970 Dec; 77(6):1100-1. PubMed ID: 5486632
    [No Abstract]   [Full Text] [Related]  

  • 13. [3 cases of malignant lymphoma or pseudolymphoma in epileptics treated with diphenylhydantoin].
    Alberto P; Cougn R; Maurice P; Weber J
    Schweiz Med Wochenschr; 1971 Dec; 101(49):1773-4. PubMed ID: 5140914
    [No Abstract]   [Full Text] [Related]  

  • 14. Phenytoin-induced pseudolymphoma: reevaluation using modern molecular biology techniques.
    Jeng YM; Tien HF; Su IJ
    Epilepsia; 1996 Jan; 37(1):104-7. PubMed ID: 8603615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycosis fungoides-like lesions associated with phenytoin therapy.
    Wolf R; Kahane E; Sandbank M
    Arch Dermatol; 1985 Sep; 121(9):1181-2. PubMed ID: 4037845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Case of "exanthematous pseudolymphoma" due to diphenylhydantoin hypersensitivity with a transitory immunologic deficit].
    Vellucci A; Galanti G; Pezzella B; De Longis P; Colacecchi C
    Clin Ter; 1980 Jul; 94(2):229-37. PubMed ID: 7449346
    [No Abstract]   [Full Text] [Related]  

  • 17. [Phenothiazine-induced pseudolymphoma].
    Blazejak T; Hölzle E
    Hautarzt; 1990 Mar; 41(3):161-3. PubMed ID: 2111802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report of antiepileptic drug hypersensitivity reaction: pseudolymphoma syndrome.
    Black DM; Fivenson DP
    Fam Pract Res J; 1989; 8(2):107-11. PubMed ID: 2662706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pseudolymphoma induced by cyclosporin].
    Bagot M; Wechsler J; Perrussel M; Robbiola O; Debure C; Dubertret L
    Ann Dermatol Venereol; 1989; 116(11):894-6. PubMed ID: 2619199
    [No Abstract]   [Full Text] [Related]  

  • 20. Phenytoin and the pseudolymphoma syndrome.
    Oates RK; Tonge RE
    Med J Aust; 1971 Aug; 2(7):371-3. PubMed ID: 5092894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.